Determination of pancreatic and gut glucagon-like immunoreactivity (GLI) in normal and diabetic subjects.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D000937:Antigen-Antibody Reactions; D001786:Blood Glucose / Q000032:analysis; D003920:Diabetes Mellitus / Q000097:blood / Q000276:immunology*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000276:immunology*; D005260:Female; D005934:Glucagon / Q000097:blood*; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology; D005951:Glucose Tolerance Test; D006801:Humans; D007422:Intestines; D007457:Iodine Radioisotopes; D008297:Male; D008875:Middle Aged; D010179:Pancreas; D011817:Rabbits / Q000276:immunology; D011863:Radioimmunoassay
D001786:Blood Glucose; D007457:Iodine Radioisotopes; D005934:Glucagon; D005947:Glucose